Literature DB >> 18240246

CD20 epitope masking by rituximab: comment on the article by Gunnarsson et al.

Y K O Teng, A Ioan-Facsinay, Jacob M van Laar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18240246     DOI: 10.1002/art.23298

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  4 in total

1.  Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease.

Authors:  David M Burns; Gordon B Ryan; Caroline M Harvey; Eszter Nagy; Simon Hughes; Paul G Murray; Nigel H Russell; Christopher P Fox; Heather M Long
Journal:  Front Immunol       Date:  2019-10-29       Impact factor: 7.561

2.  Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation.

Authors:  Terrance J Y Ku; Rafaela V P Ribeiro; Victor H Ferreira; Marcos Galasso; Shaf Keshavjee; Deepali Kumar; Marcelo Cypel; Atul Humar
Journal:  EBioMedicine       Date:  2020-09-16       Impact factor: 8.143

3.  Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients.

Authors:  Laura S van Dam; Jelle M Oskam; Sylvia W A Kamerling; Eline J Arends; O W Bredewold; Magdalena A Berkowska; Jacques J M van Dongen; Ton J Rabelink; Cees van Kooten; Y K Onno Teng
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

4.  Targeted therapies in rheumatoid arthritis: Focus on rituximab.

Authors:  Y K Teng; T W Huizinga; J M van Laar
Journal:  Biologics       Date:  2007-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.